Your search returned 24 results.

Results
	21.	Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer. [electronic resource] by Stinchcombe, Thomas E Hodgson, Lydia Herndon, James E Kelley, Michael J Cicchetti, M Giulia Ramnath, Nithya Niell, Harvey B Atkins, James N Akerley, Wallace Green, Mark R Vokes, Everett E Producer: 20091103 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. [electronic resource] by Edelman, Martin J Watson, Dee Wang, Xiaofei Morrison, Carl Kratzke, Robert A Jewell, Scott Hodgson, Lydia Mauer, Ann M Gajra, Ajeet Masters, Gregory A Bedor, Michelle Vokes, Everett E Green, Mark J Producer: 20080228 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials. [electronic resource] by Wang, Xiaofei Wang, Xiaoyi Hodgson, Lydia George, Stephen L Sargent, Daniel J Foster, Nate R Ganti, Apar Kishor Stinchcombe, Thomas E Crawford, Jeffrey Kratzke, Robert Adjei, Alex A Kindler, Hedy L Vokes, Everett E Pang, Herbert Producer: 20180129 In: The oncologist vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	24.	Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance). [electronic resource] by Edelman, Martin J Wang, Xiaofei Hodgson, Lydia Cheney, Richard T Baggstrom, Maria Q Thomas, Sachdev P Gajra, Ajeet Bertino, Erin Reckamp, Karen L Molina, Julian Schiller, Joan H Mitchell-Richards, Kisha Friedman, Paula N Ritter, Jon Milne, Ginger Hahn, Olwen M Stinchcombe, Thomas E Vokes, Everett E Producer: 20170825 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)